Simplex Trading
EDIT icon

Simplex Trading’s Editas Medicine EDIT Stock Holding History

Simplex Trading’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.6K Sell
12,400
-238,500
-95% -$505K ﹤0.01% 6364
2025
Q4 		$514K Sell
250,900
-16,800
-6% -$48.5K ﹤0.01% 3280
2025
Q3 		$928K Buy
267,700
+100,000
+60% +$279K ﹤0.01% 3131
2025
Q2 		$368K Buy
167,700
+50,800
+43% +$83.1K ﹤0.01% 3840
2025
Q1 		$135K Buy
116,900
+81,200
+227% +$119K ﹤0.01% 4742
2024
Q4 		$45K Buy
35,700
+4,800
+16% +$12.2K ﹤0.01% 5983
2024
Q3 		$105K Buy
30,900
+3,700
+14% +$16.1K ﹤0.01% 5180
2024
Q2 		$127K Sell
27,200
-78,700
-74% -$444K ﹤0.01% 5123
2024
Q1 		$785K Sell
105,900
-154,800
-59% -$1.29M ﹤0.01% 3374
2023
Q4 		$2.64M Buy
260,700
+103,200
+66% +$906K ﹤0.01% 2131
2023
Q3 		$1.23M Sell
157,500
-4,600
-3% -$39.4K ﹤0.01% 2475
2023
Q2 		$1.33M Buy
162,100
+10,500
+7% +$91.5K ﹤0.01% 2323
2023
Q1 		$1.1M Sell
151,600
-31,100
-17% -$277K ﹤0.01% 2513
2022
Q4 		$1.62M Buy
182,700
+16,900
+10% +$186K ﹤0.01% 2028
2022
Q3 		$2.03M Sell
165,800
-26,300
-14% -$410K ﹤0.01% 1940
2022
Q2 		$2.27M Sell
192,100
-35,300
-16% -$473K ﹤0.01% 1745
2022
Q1 		$4.33M Buy
227,400
+154,300
+211% +$2.87M ﹤0.01% 1379
2021
Q4 		$1.94M Sell
73,100
-17,500
-19% -$602K ﹤0.01% 2077
2021
Q3 		$5.12M Buy
90,600
+8,400
+10% +$460K ﹤0.01% 1192
2021
Q2 		$4.66M Buy
+82,200
New +$3.04M ﹤0.01% 1245
2021
Q1 		– Sell
-997
Closed -$6.99M – 9075
2020
Q4 		$6.99M Buy
997
+339
+52% +$13.9K 0.01% 765
2020
Q3 		$1.85M Buy
658
+357
+119% +$11.6K ﹤0.01% 1615
2020
Q2 		$890K Buy
301
+6
+2% +$157 ﹤0.01% 2248
2020
Q1 		$584K Sell
295
-261
-47% -$6.58K ﹤0.01% 2430
2019
Q4 		$1.65M Buy
556
+106
+24% +$2.65K ﹤0.01% 1647
2019
Q3 		$1.02M Sell
450
-113
-20% -$2.8K ﹤0.01% 1916
2019
Q2 		$1.39M Buy
563
+384
+215% +$9.17K ﹤0.01% 1607
2019
Q1 		$437K Buy
179
+39
+28% +$883 ﹤0.01% 2792
2018
Q4 		$318K Sell
140
-174
-55% -$4.74K ﹤0.01% 2659
2018
Q3 		$999K Buy
314
+135
+75% +$4.36K ﹤0.01% 1889
2018
Q2 		$641K Sell
179
-40
-18% -$1.42K ﹤0.01% 2214
2018
Q1 		$53K Buy
219
+64
+41% +$2.28K ﹤0.01% 2378
2017
Q4 		$66K Sell
155
-167
-52% -$4.21K ﹤0.01% 2167
2017
Q3 		$47K Buy
322
+12
+4% +$228 ﹤0.01% 2362
2017
Q2 		$30K Sell
310
-119
-28% -$2.15K ﹤0.01% 2882
2017
Q1 		$68K Buy
429
+340
+382% +$7.05K ﹤0.01% 2075
2016
Q4 		$11K Buy
89
+64
+256% +$971 ﹤0.01% 3633
2016
Q3 		$2K Buy
+25
New +$512 ﹤0.01% 4928

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Simplex Trading's EDIT Position: Q1 2026 in Review

Simplex Trading reduced its Editas Medicine (EDIT) stake by 96% in Q1 2026, selling an estimated $283K and leaving 5,981 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #7009.

Simplex Trading first reported a position in EDIT in Q3 2016 and has held it in 33 quarters since. The position peaked at $5.42M in Q3 2021. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Simplex Trading held 5,981 shares of Editas Medicine worth $14.8K as of Q1 2026.
  • Simplex Trading sold 133,791 Editas Medicine shares in Q1 2026, an estimated $283K.
  • Editas Medicine made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7009 holding.
  • Simplex Trading first reported a position in Editas Medicine in Q3 2016 and has held it in 33 quarters since.
  • Simplex Trading's Editas Medicine position peaked at $5.42M in Q3 2021.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.